Skin Infections in Pregnancy
Abstract A wide array of infectious diseases can occur in pregnancy. Their acquisition, clinical presentation, and course during gestation may be altered due to an impairment of the maternal cellular immunity. Some infectious diseases can lead to serious consequences for the mother and/or the offspr...
Gespeichert in:
| Veröffentlicht in: | Clinics in dermatology 2016-05, Vol.34 (3), p.368-377 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 377 |
|---|---|
| container_issue | 3 |
| container_start_page | 368 |
| container_title | Clinics in dermatology |
| container_volume | 34 |
| creator | Müllegger, Robert R., MD Häring, Nina S., MD Glatz, Martin, MD |
| description | Abstract A wide array of infectious diseases can occur in pregnancy. Their acquisition, clinical presentation, and course during gestation may be altered due to an impairment of the maternal cellular immunity. Some infectious diseases can lead to serious consequences for the mother and/or the offspring, including congenital malformations. This review describes in detail the clinical presentation, course, management, and associated maternal/fetal risks of selected viral (varicella zoster virus infections, condylomata acuminata), fungal (candida vulvovaginitis), bacterial (Lyme borreliosis), and parasitic (scabies) infections. The treatment options are critically reviewed. First-line therapies include acyclovir and varicella zoster virus immunoglobulin for varicella zoster virus infections, surgical modalities for genital warts, topical clotrimazole and oral fluconazole for candida vulvovaginitis, amoxicillin and cefuroxime for Lyme borreliosis, and permethrin for scabies. A synopsis of maternal and fetal risks of other important infections is also included. |
| doi_str_mv | 10.1016/j.clindermatol.2016.02.009 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1794473269</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0738081X16300244</els_id><sourcerecordid>1794473269</sourcerecordid><originalsourceid>FETCH-LOGICAL-c435t-42838450f5e5cc6bf14459b39d972d790cbc314ee2473596c841fe0f83161c1c3</originalsourceid><addsrcrecordid>eNqNkU1LAzEQhoMoWj_-gUjx5GXXmST7EQ-C1K9CQUEFb2GbnZXUbVaTVui_N0tVxJOnIcPzzpBnGDtGSBEwP52lprWuJj-vFl2b8thLgacAaoMNsCxUgihwkw2gEGUCJT7vsN0QZgAgIYdttsMLnmdQZAN2-PBq3XDsGjIL27kwjK97Ty-ucma1z7aaqg108FX32NP11ePoNpnc3YxHF5PESJEtEslLUcoMmowyY_Jpg1JmaipUrQpeFwrM1AiURFwWIlO5KSU2BE0pMEeDRuyxk_XcN9-9Lyks9NwGQ21bOeqWQWOhZIzyXEX0bI0a34XgqdFv3s4rv9IIurejZ_q3Hd3b0cB1tBPDR197ltM51T_Rbx0RuFwDFH_7YcnrYCw5Q7X1UZCuO_u_Ped_xvSoNVX7SisKs27pXfSpUYcY0A_9nfozYS4AuJTiE1Odj1c</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1794473269</pqid></control><display><type>article</type><title>Skin Infections in Pregnancy</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Müllegger, Robert R., MD ; Häring, Nina S., MD ; Glatz, Martin, MD</creator><creatorcontrib>Müllegger, Robert R., MD ; Häring, Nina S., MD ; Glatz, Martin, MD</creatorcontrib><description>Abstract A wide array of infectious diseases can occur in pregnancy. Their acquisition, clinical presentation, and course during gestation may be altered due to an impairment of the maternal cellular immunity. Some infectious diseases can lead to serious consequences for the mother and/or the offspring, including congenital malformations. This review describes in detail the clinical presentation, course, management, and associated maternal/fetal risks of selected viral (varicella zoster virus infections, condylomata acuminata), fungal (candida vulvovaginitis), bacterial (Lyme borreliosis), and parasitic (scabies) infections. The treatment options are critically reviewed. First-line therapies include acyclovir and varicella zoster virus immunoglobulin for varicella zoster virus infections, surgical modalities for genital warts, topical clotrimazole and oral fluconazole for candida vulvovaginitis, amoxicillin and cefuroxime for Lyme borreliosis, and permethrin for scabies. A synopsis of maternal and fetal risks of other important infections is also included.</description><identifier>ISSN: 0738-081X</identifier><identifier>EISSN: 1879-1131</identifier><identifier>DOI: 10.1016/j.clindermatol.2016.02.009</identifier><identifier>PMID: 27265075</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Candidiasis, Vulvovaginal - drug therapy ; Candidiasis, Vulvovaginal - transmission ; Cesarean Section ; Chickenpox - complications ; Chickenpox - congenital ; Chickenpox - drug therapy ; Chickenpox - transmission ; Condylomata Acuminata - therapy ; Dermatology ; Female ; Fetal Diseases - microbiology ; Herpes Zoster - drug therapy ; Herpes Zoster - transmission ; Humans ; Infectious Disease Transmission, Vertical - prevention & control ; Lyme Disease - complications ; Lyme Disease - drug therapy ; Pregnancy ; Pregnancy Complications, Infectious - microbiology ; Pregnancy Complications, Infectious - therapy ; Pregnancy Complications, Parasitic - drug therapy ; Pregnancy Outcome ; Scabies - drug therapy ; Skin Diseases, Infectious - microbiology ; Skin Diseases, Infectious - therapy ; Skin Diseases, Infectious - transmission</subject><ispartof>Clinics in dermatology, 2016-05, Vol.34 (3), p.368-377</ispartof><rights>2016 Elsevier Inc.</rights><rights>Copyright © 2016 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c435t-42838450f5e5cc6bf14459b39d972d790cbc314ee2473596c841fe0f83161c1c3</citedby><cites>FETCH-LOGICAL-c435t-42838450f5e5cc6bf14459b39d972d790cbc314ee2473596c841fe0f83161c1c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.clindermatol.2016.02.009$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27265075$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Müllegger, Robert R., MD</creatorcontrib><creatorcontrib>Häring, Nina S., MD</creatorcontrib><creatorcontrib>Glatz, Martin, MD</creatorcontrib><title>Skin Infections in Pregnancy</title><title>Clinics in dermatology</title><addtitle>Clin Dermatol</addtitle><description>Abstract A wide array of infectious diseases can occur in pregnancy. Their acquisition, clinical presentation, and course during gestation may be altered due to an impairment of the maternal cellular immunity. Some infectious diseases can lead to serious consequences for the mother and/or the offspring, including congenital malformations. This review describes in detail the clinical presentation, course, management, and associated maternal/fetal risks of selected viral (varicella zoster virus infections, condylomata acuminata), fungal (candida vulvovaginitis), bacterial (Lyme borreliosis), and parasitic (scabies) infections. The treatment options are critically reviewed. First-line therapies include acyclovir and varicella zoster virus immunoglobulin for varicella zoster virus infections, surgical modalities for genital warts, topical clotrimazole and oral fluconazole for candida vulvovaginitis, amoxicillin and cefuroxime for Lyme borreliosis, and permethrin for scabies. A synopsis of maternal and fetal risks of other important infections is also included.</description><subject>Candidiasis, Vulvovaginal - drug therapy</subject><subject>Candidiasis, Vulvovaginal - transmission</subject><subject>Cesarean Section</subject><subject>Chickenpox - complications</subject><subject>Chickenpox - congenital</subject><subject>Chickenpox - drug therapy</subject><subject>Chickenpox - transmission</subject><subject>Condylomata Acuminata - therapy</subject><subject>Dermatology</subject><subject>Female</subject><subject>Fetal Diseases - microbiology</subject><subject>Herpes Zoster - drug therapy</subject><subject>Herpes Zoster - transmission</subject><subject>Humans</subject><subject>Infectious Disease Transmission, Vertical - prevention & control</subject><subject>Lyme Disease - complications</subject><subject>Lyme Disease - drug therapy</subject><subject>Pregnancy</subject><subject>Pregnancy Complications, Infectious - microbiology</subject><subject>Pregnancy Complications, Infectious - therapy</subject><subject>Pregnancy Complications, Parasitic - drug therapy</subject><subject>Pregnancy Outcome</subject><subject>Scabies - drug therapy</subject><subject>Skin Diseases, Infectious - microbiology</subject><subject>Skin Diseases, Infectious - therapy</subject><subject>Skin Diseases, Infectious - transmission</subject><issn>0738-081X</issn><issn>1879-1131</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU1LAzEQhoMoWj_-gUjx5GXXmST7EQ-C1K9CQUEFb2GbnZXUbVaTVui_N0tVxJOnIcPzzpBnGDtGSBEwP52lprWuJj-vFl2b8thLgacAaoMNsCxUgihwkw2gEGUCJT7vsN0QZgAgIYdttsMLnmdQZAN2-PBq3XDsGjIL27kwjK97Ty-ucma1z7aaqg108FX32NP11ePoNpnc3YxHF5PESJEtEslLUcoMmowyY_Jpg1JmaipUrQpeFwrM1AiURFwWIlO5KSU2BE0pMEeDRuyxk_XcN9-9Lyks9NwGQ21bOeqWQWOhZIzyXEX0bI0a34XgqdFv3s4rv9IIurejZ_q3Hd3b0cB1tBPDR197ltM51T_Rbx0RuFwDFH_7YcnrYCw5Q7X1UZCuO_u_Ped_xvSoNVX7SisKs27pXfSpUYcY0A_9nfozYS4AuJTiE1Odj1c</recordid><startdate>20160501</startdate><enddate>20160501</enddate><creator>Müllegger, Robert R., MD</creator><creator>Häring, Nina S., MD</creator><creator>Glatz, Martin, MD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20160501</creationdate><title>Skin Infections in Pregnancy</title><author>Müllegger, Robert R., MD ; Häring, Nina S., MD ; Glatz, Martin, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c435t-42838450f5e5cc6bf14459b39d972d790cbc314ee2473596c841fe0f83161c1c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Candidiasis, Vulvovaginal - drug therapy</topic><topic>Candidiasis, Vulvovaginal - transmission</topic><topic>Cesarean Section</topic><topic>Chickenpox - complications</topic><topic>Chickenpox - congenital</topic><topic>Chickenpox - drug therapy</topic><topic>Chickenpox - transmission</topic><topic>Condylomata Acuminata - therapy</topic><topic>Dermatology</topic><topic>Female</topic><topic>Fetal Diseases - microbiology</topic><topic>Herpes Zoster - drug therapy</topic><topic>Herpes Zoster - transmission</topic><topic>Humans</topic><topic>Infectious Disease Transmission, Vertical - prevention & control</topic><topic>Lyme Disease - complications</topic><topic>Lyme Disease - drug therapy</topic><topic>Pregnancy</topic><topic>Pregnancy Complications, Infectious - microbiology</topic><topic>Pregnancy Complications, Infectious - therapy</topic><topic>Pregnancy Complications, Parasitic - drug therapy</topic><topic>Pregnancy Outcome</topic><topic>Scabies - drug therapy</topic><topic>Skin Diseases, Infectious - microbiology</topic><topic>Skin Diseases, Infectious - therapy</topic><topic>Skin Diseases, Infectious - transmission</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Müllegger, Robert R., MD</creatorcontrib><creatorcontrib>Häring, Nina S., MD</creatorcontrib><creatorcontrib>Glatz, Martin, MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinics in dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Müllegger, Robert R., MD</au><au>Häring, Nina S., MD</au><au>Glatz, Martin, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Skin Infections in Pregnancy</atitle><jtitle>Clinics in dermatology</jtitle><addtitle>Clin Dermatol</addtitle><date>2016-05-01</date><risdate>2016</risdate><volume>34</volume><issue>3</issue><spage>368</spage><epage>377</epage><pages>368-377</pages><issn>0738-081X</issn><eissn>1879-1131</eissn><abstract>Abstract A wide array of infectious diseases can occur in pregnancy. Their acquisition, clinical presentation, and course during gestation may be altered due to an impairment of the maternal cellular immunity. Some infectious diseases can lead to serious consequences for the mother and/or the offspring, including congenital malformations. This review describes in detail the clinical presentation, course, management, and associated maternal/fetal risks of selected viral (varicella zoster virus infections, condylomata acuminata), fungal (candida vulvovaginitis), bacterial (Lyme borreliosis), and parasitic (scabies) infections. The treatment options are critically reviewed. First-line therapies include acyclovir and varicella zoster virus immunoglobulin for varicella zoster virus infections, surgical modalities for genital warts, topical clotrimazole and oral fluconazole for candida vulvovaginitis, amoxicillin and cefuroxime for Lyme borreliosis, and permethrin for scabies. A synopsis of maternal and fetal risks of other important infections is also included.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>27265075</pmid><doi>10.1016/j.clindermatol.2016.02.009</doi><tpages>10</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0738-081X |
| ispartof | Clinics in dermatology, 2016-05, Vol.34 (3), p.368-377 |
| issn | 0738-081X 1879-1131 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1794473269 |
| source | MEDLINE; Access via ScienceDirect (Elsevier) |
| subjects | Candidiasis, Vulvovaginal - drug therapy Candidiasis, Vulvovaginal - transmission Cesarean Section Chickenpox - complications Chickenpox - congenital Chickenpox - drug therapy Chickenpox - transmission Condylomata Acuminata - therapy Dermatology Female Fetal Diseases - microbiology Herpes Zoster - drug therapy Herpes Zoster - transmission Humans Infectious Disease Transmission, Vertical - prevention & control Lyme Disease - complications Lyme Disease - drug therapy Pregnancy Pregnancy Complications, Infectious - microbiology Pregnancy Complications, Infectious - therapy Pregnancy Complications, Parasitic - drug therapy Pregnancy Outcome Scabies - drug therapy Skin Diseases, Infectious - microbiology Skin Diseases, Infectious - therapy Skin Diseases, Infectious - transmission |
| title | Skin Infections in Pregnancy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T05%3A05%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Skin%20Infections%20in%20Pregnancy&rft.jtitle=Clinics%20in%20dermatology&rft.au=M%C3%BCllegger,%20Robert%20R.,%20MD&rft.date=2016-05-01&rft.volume=34&rft.issue=3&rft.spage=368&rft.epage=377&rft.pages=368-377&rft.issn=0738-081X&rft.eissn=1879-1131&rft_id=info:doi/10.1016/j.clindermatol.2016.02.009&rft_dat=%3Cproquest_cross%3E1794473269%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1794473269&rft_id=info:pmid/27265075&rft_els_id=S0738081X16300244&rfr_iscdi=true |